158 related articles for article (PubMed ID: 33360796)
1. Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors.
Ammazzalorso A; Gallorini M; Fantacuzzi M; Gambacorta N; De Filippis B; Giampietro L; Maccallini C; Nicolotti O; Cataldi A; Amoroso R
Eur J Med Chem; 2021 Feb; 211():113115. PubMed ID: 33360796
[TBL] [Abstract][Full Text] [Related]
2. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
Banjare L
Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
[TBL] [Abstract][Full Text] [Related]
3. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors.
Giampietro L; Gallorini M; Gambacorta N; Ammazzalorso A; De Filippis B; Della Valle A; Fantacuzzi M; Maccallini C; Mollica A; Cataldi A; Nicolotti O; Amoroso R
Eur J Med Chem; 2021 Nov; 224():113737. PubMed ID: 34365129
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors.
Doiron J; Soultan AH; Richard R; Touré MM; Picot N; Richard R; Cuperlović-Culf M; Robichaud GA; Touaibia M
Eur J Med Chem; 2011 Sep; 46(9):4010-24. PubMed ID: 21703734
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of benzoxazolinonic imidazoles and derivatives as non-steroidal aromatase inhibitors.
Nativelle-Serpentini C; Moslemi S; Yous S; Park CH; Lesieur D; Sourdaine P; Séralini GE
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):119-27. PubMed ID: 15449726
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and aromatase inhibitory evaluation of 4-N-nitrophenyl substituted amino-4H-1,2,4-triazole derivatives.
Song Z; Liu Y; Dai Z; Liu W; Zhao K; Zhang T; Hu Y; Zhang X; Dai Y
Bioorg Med Chem; 2016 Oct; 24(19):4723-4730. PubMed ID: 27567077
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a new class of cinnamyl-triazole as potent and selective inhibitors of aromatase (cytochrome P450 19A1).
McNulty J; Keskar K; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2014 Sep; 24(18):4586-4589. PubMed ID: 25155384
[TBL] [Abstract][Full Text] [Related]
14. Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors.
Chamduang C; Pingaew R; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Chem; 2019 Dec; 93():103327. PubMed ID: 31614285
[TBL] [Abstract][Full Text] [Related]
15. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.
Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ
Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in vitro and in silico studies of some novel thiazole-dihydrofuran derivatives as aromatase inhibitors.
Osmaniye D; Görgülü Ş; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Bioorg Chem; 2021 Sep; 114():105123. PubMed ID: 34214753
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitors--mechanisms for non-steroidal inhibitors.
Vanden Bossche HV; Moereels H; Koymans LM
Breast Cancer Res Treat; 1994; 30(1):43-55. PubMed ID: 7949204
[TBL] [Abstract][Full Text] [Related]
19. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
[TBL] [Abstract][Full Text] [Related]
20. Novel 1,2,3-Triazole Derivatives as Mimics of Steroidal System-Synthesis, Crystal Structures Determination, Hirshfeld Surfaces Analysis and Molecular Docking.
Daśko M; Dołęga A; Siedzielnik M; Biernacki K; Ciupak O; Rachon J; Demkowicz S
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
